CardioNet Terminates Merger With Biotel
Biotel President and CEO Steve Springrose said: "It is unfortunate that CardioNet took this action. Biotel has developed significant new products in wireless MCT and event recorder applications. These products are of significant value to arrhythmia service organizations, and Biotel believes these products are cost effective and well positioned for the current medical reimbursement climate. Biotel has worked to build its shareholder value by expanding its range of products and services. Biotel will continue to position these new wireless products to maximize growth and opportunities going forward."
Biotel supplies completed medical devices and clinical research services to medical companies including
-- ECG diagnostic products -- wireless MCT and event recorders, Holter recorders, -- tissue management devices, and -- 24/7 clinical ECG research services
SOURCE Biotel Inc.
You May Also Like